EUVIMEDEUVIMED entdecken
Vergleichsstudie

Comparative Study of Pyridine and Pyrimidine Derivatives as Promising Anti‐Inflammatory Agents: Design, Synthesis, and LPS‐Induced RAW 264.7 Macrophages

Farid M Sroor iD, Ahmed A F Soliman, Wagdy K B Khalil, Khaled Mahmoud

Drug Development Research · 2025-09 · 86 (6)

DOI: 10.1002/ddr.70146 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift Drug Development Research, online erschienen am 13.08.2025. Verfasst von Farid M Sroor und 3 weiteren Autor:innen. Beteiligte Einrichtung: Organometallic and Organometalloid Chemistry Department, National Research Centre, Cairo, Egypt. Hauptthemen laut MEDLINE: Pyrimidines, Pyridines, Anti-Inflammatory Agents, Macrophages. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 56 Literaturangaben. Gefördert von: The authors received no specific funding for this work..

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

In this study, we aimed to design and synthesize a novel series of pyridine and pyrimidine derivatives and evaluate their anti‐inflammatory activity against RAW 264.7 macrophages. Using chalcones ( 5a−f ) as suitable precursors, we disclosed a novel series of pyridine ( 7a−f ) and pyrimidine ( 9a−e ) derivatives via the reaction of 5a−f with 2‐cyanothioacetamide or guanidine hydrochloride, respectively. Both pyridines and pyrimidines were tested as anti‐inflammatory agents to compare the difference in activity of the pyridine and pyrimidine scaffolds as part of a comparative study. With a percentage of live cells greater than 80%, the pyridines ( 7a−f ) and pyrimidines ( 9a−e ) were found to be safe for RAW cells. Moreover, the anti‐inflammatory activity of these compounds was evaluated in lipopolysaccharide (LPS)‐stimulated RAW macrophages by performing nitric oxide (NO) assays. Among pyridines, 7a and 7f showed significant inhibition with 65.48% and 51.19%, with IC 50 values (IC 50 = 76.6 and 96.8 µM), respectively. The pyrimidine derivatives showed promising results as well, 9a and 9d ranking the best activity with 55.95% and 61.90%, respectively, and IC 50 values (IC 50 = 83.1 and 88.7 µM, respectively). The gene expression levels were assessed for the most promising compounds 7a and 9d using real‐time reverse transcription‐polymerase chain reaction analysis to measure the mRNA and protein expression levels of inflammatory cytokines, including interleukin‐1 (IL‐1), interleukin‐6 (IL‐6), tumor necrosis factor‐alpha (TNF‐ɑ), nuclear factor kappa β (NF‐kβ), and inducible nitric oxide synthase (INOS). The expression levels of IL‐1, IL‐6, TNF‐ ɑ , NF‐kβ, and INOS genes were decreased significantly in RAW‐treated cells with 7a by 43%, 32%, 61%, 26%, and 53% respectively, compared with negative RAW cells. The expression levels of IL‐1, IL‐6, NF‐k β , and INOS genes were decreased significantly in RAW‐treated cells with 9d by 71%, 48%, 61%, and 65%, respectively, compared with negative RAW cells. However, the expression levels of the TNF‐ɑ gene were decreased without significant differences in RAW treated with 9d by 83% ( p > 0.05) compared with negative RAW cells. These findings exhibited that 7a was more effective compared with 9d as an anti‐inflammatory agent.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PyrimidinesPyridinesAnti-Inflammatory AgentsMacrophagesAnimalsMiceLipopolysaccharidesRAW 264.7 CellsDrug DesignNitric OxideNitric Oxide Synthase Type II

Stichwörter der Autor:innen

RAW 264.7anti‐inflammatorychalconesgene expressionpyridinespyrimidines

Substanzen

LipopolysaccharidesPyrimidinesPyridinesAnti-Inflammatory AgentsNitric OxideNitric Oxide Synthase Type IIpyrimidine

Autor:innen und Institutionen

  • Organometallic and Organometalloid Chemistry Department, National Research Centre, Cairo, Egypt.
  • Pharmacognosy Department, National Research Centre, Dokki, Egypt.
  • Cell Biology Department, National Research Centre, Giza, Egypt.

ORCID-Profile: Farid M Sroor

Förderung

  • The authors received no specific funding for this work.

Zitieren

APA

Sroor, F. M., Soliman, A. A. F., Khalil, W. K. B., & Mahmoud, K. (2025). Comparative Study of Pyridine and Pyrimidine Derivatives as Promising Anti‐Inflammatory Agents: Design, Synthesis, and LPS‐Induced RAW 264.7 Macrophages. Drug Development Research, 86(6). https://doi.org/10.1002/ddr.70146

Vancouver

Sroor FM, Soliman AAF, Khalil WKB, Mahmoud K. Comparative Study of Pyridine and Pyrimidine Derivatives as Promising Anti‐Inflammatory Agents: Design, Synthesis, and LPS‐Induced RAW 264.7 Macrophages. Drug Development Research. 2025;86(6). doi:10.1002/ddr.70146

BibTeX
@article{Sroor2025,
  author = {Sroor, Farid M and Soliman, Ahmed A F and Khalil, Wagdy K B and Mahmoud, Khaled},
  title = {Comparative Study of Pyridine and Pyrimidine Derivatives as Promising Anti‐Inflammatory Agents: Design, Synthesis, and LPS‐Induced RAW 264.7 Macrophages},
  journal = {Drug Development Research},
  year = {2025},
  volume = {86},
  number = {6},
  doi = {10.1002/ddr.70146}
}
Kostenlos starten →